TRAFALGAR INTERNATIONAL, INC.

Overview

Compare with Advaxis, PRF Technologies Ltd. or BIOADAPTIVES, INC., or pick any stock.

• TickerGCAN on OTC¹
• IndustryPharmaceutical Preparations¹
• HeadquartersMiami, Florida¹
• Incorporated inFL²
• Business address200 South Biscayne Blvd Fl 20, Miami, Fl 33131²
• Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Greater Cannabis Company, LLC. The Company was a wholly owned subsidiary of Sylios Corp (“Sylios”) until March 10, 2017.³ From its latest annual report

Corporate structure

TRAFALGAR INTERNATIONAL, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What TRAFALGAR INTERNATIONAL, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Properties, in its own words

We currently lease office space at 15 Walker Street, Suite 101, Baltimore, Maryland 21208 from our chief executive officer, Aitan Zacharin, for no consideration. Our lease with Mr. Zacharin is terminable at will.

We do not own any real property.

Item 2 of the 10-K filed Mar 31, 2026.³

Leadership

Who has led TRAFALGAR INTERNATIONAL, INC., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerTalavera Porfirio Sanchez Jul 16, 2026 to now¹¹
• Chief executive officerAitan Zacharin Apr 10, 2025 to Jul 16, 2026¹²
• ChairTalavera Porfirio Sanchez Jul 16, 2026 to now¹¹

Former names

• Greater Cannabis Company, Inc.Jun 20, 2017 to Jul 31, 2026²

Timeline

1. Oct 14, 20268-K Bylaws or fiscal year changed; Other events¹³
2. Sep 21, 20268-K Executive or director change¹⁴
3. Jul 31, 20268-K Executive or director change; Bylaws or fiscal year changed; Other events¹⁵
4. Jul 16, 2026New chief executive Talavera Porfirio Sanchez becomes CEO¹¹
5. Jul 6, 20268-K Entered a material agreement; Change in control; Executive or director change¹⁶
6. Oct 27, 20258-K Bylaws or fiscal year changed; Other events¹⁷
7. Oct 16, 20258-K Bylaws or fiscal year changed; Other events¹⁸
8. Oct 15, 20258-K Bylaws or fiscal year changed; Other events¹⁹
9. Apr 10, 2025New chief executive Aitan Zacharin becomes CEO¹²
10. Apr 10, 20258-K Unregistered sale of shares; Executive or director change²⁰
11. Mar 6, 20258-K Change of auditor²¹
12. Aug 16, 20238-K Bylaws or fiscal year changed²²
13. Jan 26, 20238-K Change of auditor²³
14. Jun 21, 20228-K Entered a material agreement²⁴

Filings

54 filings to the SEC since October 2021: 6 annual reports, 16 quarterly reports, 15 major events, 4 insider forms, 1 large holders, 12 other. The latest 20:

1. Oct 14, 2026PRE 14C EDGAR
2. Oct 14, 20268-K EDGAR
3. Sep 21, 20268-K EDGAR
4. Aug 14, 202610-Q EDGAR
5. Jul 31, 2026SC 14F1 EDGAR
6. Jul 31, 20268-K EDGAR
7. Jul 16, 2026SCHEDULE 13D EDGAR
8. Jul 16, 20263 EDGAR
9. Jul 16, 20263 EDGAR
10. Jul 6, 2026SC 14F1 EDGAR
11. Jul 6, 20268-K EDGAR
12. May 13, 202610-Q EDGAR
13. Mar 31, 202610-K EDGAR
14. Nov 12, 202510-Q EDGAR
15. Oct 27, 20258-K EDGAR
16. Oct 16, 20258-K/A EDGAR
17. Oct 15, 20258-K EDGAR
18. Aug 8, 202510-Q EDGAR
19. Aug 8, 202510-Q/A EDGAR
20. May 22, 2025UPLOAD EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Trafalgar Asset Management, LLCSCHEDULE 13D, 1 filing Jul 16, 2026²⁵

SEC filer profile

How TRAFALGAR INTERNATIONAL, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARTRAFALGAR INTERNATIONAL, INC.¹
• CIK0001695473
• Employer ID (EIN)30-0842570³
• Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company³
• Incorporated inFlorida³
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address200 South Biscayne Blvd Fl 20, Miami, FL 33131¹
• Phone(443) 738-4051¹
• Shares outstanding994,379 as of Aug 14, 2026⁸
• Public float$586.1K as of Jun 30, 2025³
• AuditorALOBA, AWOMOLO & PARTNERS, Floor 4, Providence Court, Ajibade Bus Stop, Beside CocaCola Ibadan Oyo State, Nigeria PCAOB ID 7275³
• On EDGAR sinceJun 20, 2017¹
• Filings143 in all: 10-Q (27), 8-K (27), NT 10-Q (11), CORRESP (10), UPLOAD (10), 10-K (9), S-1/A (6), EFFECT (5)¹
  All 23 form types

  NT 10-K (5), 3 (4), PRE 14C (4), S-1 (4), 10-K/A (3), 10-Q/A (3), 4 (3), 8-K/A (3), DEF 14C (2), SC 14F1 (2), 8-A12G (1), POS AM (1), PRE 14A (1), PRER14C (1), SCHEDULE 13D (1)

• Latest filingsAnnual report (10-K) Mar 31, 2026
  Quarterly report (10-Q) Aug 14, 2026
  Latest 8-K (8-K) Oct 14, 2026

Risk factors and legal proceedings

Legal proceedings

We know of no pending proceedings to which any director, member of senior management, or affiliate is either a party adverse to us or has a material interest adverse to us.

None of our executive officers or directors have (i) been involved in any bankruptcy proceedings within the last five years, (ii) been convicted in or has pending any criminal proceedings (other than traffic violations and other minor offenses), (iii) been subject to any order, judgment or decree enjoining, barring, suspending or otherwise limiting involvement in any type of business, securities or banking activity or (iv) been found to have violated any Federal, state or provincial securities or commodities law and such finding has not been reversed, suspended or vacated.

The opening of Item 3, Legal Proceedings.³